Acadia Pharmaceuticals | 販売および管理費



Selling And Administration Expenses 変化する 日付
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
ALKERMES USD 171.7M 24.71M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Cytokinetics USD 57.37M 4.97M 2025-03
Eisai JPY 104.52B 7.1B 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
Incyte USD 325.69M 1.02M 2025-03
J&J USD 5.11B 1.34B 2025-03
Moderna USD 212M 139M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Prothena USD 16.85M 88K 2024-12
PTC Therapeutics USD 161.92M 77.24M 2025-03
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Acadia Pharmaceuticals 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.